238 related articles for article (PubMed ID: 35358499)
1. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.
Flores Gutiérrez J; Natali G; Giorgi J; De Leonibus E; Tongiorgi E
Exp Neurol; 2022 Jul; 353():114056. PubMed ID: 35358499
[TBL] [Abstract][Full Text] [Related]
2. Protective role of mirtazapine in adult female Mecp2
Flores Gutiérrez J; De Felice C; Natali G; Leoncini S; Signorini C; Hayek J; Tongiorgi E
J Neurodev Disord; 2020 Sep; 12(1):26. PubMed ID: 32988385
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.
Bittolo T; Raminelli CA; Deiana C; Baj G; Vaghi V; Ferrazzo S; Bernareggi A; Tongiorgi E
Sci Rep; 2016 Jan; 6():19796. PubMed ID: 26806603
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Villani C; Sacchetti G; Carli M; Invernizzi RW
Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome.
Vogel Ciernia A; Yasui DH; Pride MC; Durbin-Johnson B; Noronha AB; Chang A; Knotts TA; Rutkowsky JR; Ramsey JJ; Crawley JN; LaSalle JM
Hum Mol Genet; 2018 Dec; 27(23):4077-4093. PubMed ID: 30137367
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Supplementation Rescues Aberrant NF-κB Pathway Activation and Partially Ameliorates Rett Syndrome Phenotypes in
Ribeiro MC; Moore SM; Kishi N; Macklis JD; MacDonald JL
eNeuro; 2020; 7(3):. PubMed ID: 32393583
[TBL] [Abstract][Full Text] [Related]
8. Early motor phenotype detection in a female mouse model of Rett syndrome is improved by cross-fostering.
Vogel Ciernia A; Pride MC; Durbin-Johnson B; Noronha A; Chang A; Yasui DH; Crawley JN; LaSalle JM
Hum Mol Genet; 2017 May; 26(10):1839-1854. PubMed ID: 28334953
[TBL] [Abstract][Full Text] [Related]
9. Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.
Pan CH; Tsai S
Med Sci Monit; 2012 Jan; 18(1):HY1-3. PubMed ID: 22207122
[TBL] [Abstract][Full Text] [Related]
10. Wild-type MECP2 expression coincides with age-dependent sensory phenotypes in a female mouse model for Rett syndrome.
Mykins M; Layo-Carris D; Dunn LR; Skinner DW; McBryar AH; Perez S; Shultz TR; Willems A; Lau BYB; Hong T; Krishnan K
J Neurosci Res; 2023 Aug; 101(8):1236-1258. PubMed ID: 37026482
[TBL] [Abstract][Full Text] [Related]
11. 5-HT
Dai H; Kitami Y; Goto YI; Itoh M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430502
[TBL] [Abstract][Full Text] [Related]
12. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
13. Perineuronal net degradation rescues CA2 plasticity in a mouse model of Rett syndrome.
Carstens KE; Lustberg DJ; Shaughnessy EK; McCann KE; Alexander GM; Dudek SM
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228646
[TBL] [Abstract][Full Text] [Related]
14. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.
Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC
Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109
[TBL] [Abstract][Full Text] [Related]
15. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.
Lonetti G; Angelucci A; Morando L; Boggio EM; Giustetto M; Pizzorusso T
Biol Psychiatry; 2010 Apr; 67(7):657-65. PubMed ID: 20172507
[TBL] [Abstract][Full Text] [Related]
16. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
17. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
[TBL] [Abstract][Full Text] [Related]
18. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
[TBL] [Abstract][Full Text] [Related]
19. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
20. ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome.
Kaufmann WE; Sprouse J; Rebowe N; Hanania T; Klamer D; Missling CU
Pharmacol Biochem Behav; 2019 Dec; 187():172796. PubMed ID: 31704481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
